State Street’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.08M | Buy |
1,382,686
+238,243
| +21% | +$1.22M | ﹤0.01% | 2791 |
|
|
2025
Q1 | $1.57M | Sell |
1,144,443
-86,756
| -7% | -$119K | ﹤0.01% | 3324 |
|
|
2024
Q4 | $3.8M | Sell |
1,231,199
-1,087,009
| -47% | -$3.36M | ﹤0.01% | 3073 |
|
|
2024
Q3 | $17.9M | Buy |
2,318,208
+489,949
| +27% | +$3.77M | ﹤0.01% | 2274 |
|
|
2024
Q2 | $15.7M | Sell |
1,828,259
-1,037,839
| -36% | -$8.9M | ﹤0.01% | 2294 |
|
|
2024
Q1 | $22.8M | Buy |
2,866,098
+1,887,160
| +193% | +$15M | ﹤0.01% | 2137 |
|
|
2023
Q4 | $9.69M | Buy |
978,938
+25,059
| +3% | +$248K | ﹤0.01% | 2613 |
|
|
2023
Q3 | $10.7M | Buy |
953,879
+54,940
| +6% | +$619K | ﹤0.01% | 2554 |
|
|
2023
Q2 | $2.98M | Buy |
898,939
+77,410
| +9% | +$257K | ﹤0.01% | 3231 |
|
|
2023
Q1 | $3.25M | Sell |
821,529
-22,340
| -3% | -$88.2K | ﹤0.01% | 3149 |
|
|
2022
Q4 | $6.12M | Sell |
843,869
-28,733
| -3% | -$208K | ﹤0.01% | 2956 |
|
|
2022
Q3 | $3.16M | Buy |
872,602
+130,266
| +18% | +$472K | ﹤0.01% | 3273 |
|
|
2022
Q2 | $3.36M | Buy |
742,336
+495,202
| +200% | +$2.24M | ﹤0.01% | 3293 |
|
|
2022
Q1 | $1.87M | Buy |
247,134
+17,141
| +7% | +$130K | ﹤0.01% | 3594 |
|
|
2021
Q4 | $2.52M | Buy |
229,993
+31,893
| +16% | +$349K | ﹤0.01% | 3573 |
|
|
2021
Q3 | $2.56M | Buy |
+198,100
| New | +$2.56M | ﹤0.01% | 3542 |
|